logo Ibionextlogo Ibionext
  • HOME
  • ABOUT US
  • STRATEGY
  • TEAM
  • OUR COMPANIES
  • NEWS & MEDIA
  • CONTACT
  • Français
Twitter
LinkedIn

TILAK HEALTHCARE ANNOUNCES EXCLUSIVE PARTNERSHIP FOR CO-PROMOTION WITH NOVARTIS FRANCE

May 13, 2019Press releasesIbionext

To promote OdySight, a digital solution to optimize visual monitoring of patients with chronic eye diseases

Paris, May 13, 2019 – Tilak Healthcare, a pioneering video game studio specializing in mobile medical games for patients with chronic diseases, announces an exclusive co-promotion partnership with Novartis France for OdySight, its first clinically validated mobile game to monitor vision remotely.
Tilak Healthcare will rely on medical representatives from Novartis France to inform ophthalmologists in France of this innovation and provide greater access to this solution.
Edouard Gasser, CEO of Tilak Healthcare, comments: “We are very excited to embark on this journey alongside Novartis France. This is a major step in the growth of Tilak Healthcare. We look forward to collaborating with a partner whose ambitious digital strategy echoes our vision of combining the playful world of mobile gaming with the medical world in order to help physicians. Thanks to this partnership, Tilak strengthens its status as a major player in e-health.”
Audrey Derveloy, Head of Ophthalmology at Novartis France, comments: “We welcome this collaboration with Tilak Healthcare, which is part of our strategy based on the alliance of therapeutic and digital innovations to improve patient autonomy with « certain eye diseases”.

About OdySight
Developed by physicians and video game professionals, OdySight is a concrete example of digital solutions to improve patient care. By combining games and medical tests, the application allows close monitoring of patients with chronic ocular diseases (eg, AMD, diabetic macular edema, high myopia).
The user performs medical tests and then can progress through a puzzle game to test his cognitive and visual abilities. In case of vision loss detected by the application, an alert is sent to the patient, inviting him to make an appointment with his ophthalmologist.
OdySight, as a fun and engaging application, motivates the patient to come back on a regular basis, and therefore, to do more visual tests, in a sustainable fashion, than are normally performed during a traditional care pathway.

About Tilak Healthcare
Tilak is a unique videogame studio where like-minded & passionate people create fun, mobile medical games for patients with chronic diseases. There is an ever-increasing demand for medical services, placing a huge burden on the healthcare system. Doctors and caregivers need new, validated tools and resources in order to improve access. At Tilak, every product on the market is clinically validated, developed with physicians and patient advocates, compliant with medical device regulations, and protects the patient’s privacy.
For more information: http: //www.Tilak Healthcarehealthcare.com/

About Novartis
We believe Novartis is well prepared for a world with a growing, aging population and continuously evolving healthcare needs. We have a clear mission, focused strategy and strong culture, all of which we expect will support the creation of value over the long term for our company, our shareholders and society. Our strategy is to use science-based innovation to deliver better patient outcomes in growing areas of healthcare.
For more information, visit http://www.novartis.com

Contacts
Contact Tilak Healthcare
Edouard Gasser – +33 (0) 7 62 27 18 42 – egasser@Tilak Healthcarehealthcare.com
Press contacts – NewCap
Annie-Florence Loyer – +33 (0)1 44 71 00 12 / +33 (0)6 88 20 35 59 – afloyer@newcap.fr
Léa Jacquin – +33 (0)1 44 71 20 41 – ljacquin@newcap.fr

Previous post Chronolife announces appointment of Dr. Zarifah Reed, M.D., as Chief Medical Officer as it prepares key clinical trial across Europe Next post Chronolife, recently ISO 13 485 certified, receives CE mark approval for its Smart Textile solution and announces a strategic partnership

SEARCH

ARCHIVES

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

CATEGORIES

  • Events (3)
  • News (78)
  • Press releases (67)

LATEST NEWS

  • Théa partners with Tilak Healthcare to promote OdySight: First remote monitoring solution for ophthalmology June 29, 2022
  • GrAI Matter Labs Unveils Life-Ready AI with GrAI VIP at GLOBAL INDUSTRIE May 16, 2022
  • Rigshospitalet, the main hospital in Denmark based in Copenhagen, collaborate with Chronolife for a clinical investigation in Oncology March 31, 2022
  • Europrotect partners with Chronolife for the development and production of a device to measure physiological data, integrated into a firefighter’s intervention suit to limit the risk of thermal stress March 13, 2022
  • OdySight, first remote monitoring solution in ophthalmology to be reimbursed by the Social Security March 9, 2022

CONTACT US

74, rue du Faubourg Saint-Antoine 75012 Paris
+33 1 76 21 47 50
contact@ibionext.com

LEGAL NOTICES

  • Cookies Policy
  • Privacy Policy
  • Terms of use
© 2023 iBionext. All rights reserved